AOD9604 Clinics in the United States

What Is AOD9604?

AOD9604 is a modified fragment of human growth hormone (HGH), specifically the last 15 amino acids of the HGH molecule responsible for its fat-burning properties. It was originally developed by Monash University in Australia as an anti-obesity drug.

AOD9604 stimulates the breakdown of fat (lipolysis) and inhibits the transformation of food into body fat (lipogenesis) without affecting blood sugar or IGF-1 levels. Unlike full HGH, it does not have anabolic effects on muscle growth or significant systemic effects.

It is typically administered via subcutaneous injection or sublingually, and is often used alongside other peptides like CJC-1295 and Ipamorelin for broader body composition goals.

Who Considers AOD9604?

• Adults looking to reduce body fat as part of a supervised wellness program
• People who want to support fat loss without the broader systemic effects of HGH
• Those pursuing body composition improvement alongside diet and exercise
• Patients in peptide therapy programs targeting metabolic health

What to Expect at a Consultation

Your consultation will cover your body composition goals, current health status, and any other medications or peptides you are using. AOD9604 is often prescribed as part of a broader peptide protocol. The physician will determine appropriate dosing and administration method.